Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Central Garden & Pet Co
CENT
$2.76B
| $3.44M | ﹤0.01% |
80,400
-20,618
| -20% | -$841K |
|
|
HLVX
2427
DELISTED
HilleVax
HLVX
| $3.43M | ﹤0.01% |
206,266
-2,507
| -1% | -$40.1K |
|
|
HONE
2428
DELISTED
HarborOne Bancorp
HONE
| $3.43M | ﹤0.01% |
321,449
+9,417
| +3% | +$101K |
|
2429
TTEC Holdings
TTEC
$132M
| $3.43M | ﹤0.01% |
330,374
+48,403
| +17% | +$811K |
|
2430
OneSpan
OSPN
$601M
| $3.42M | ﹤0.01% |
294,388
+13,826
| +5% | +$142K |
|
2431
Replimune Group
REPL
$1B
| $3.42M | ﹤0.01% |
418,664
+16,722
| +4% | +$137K |
|
|
OPTU
2432
Optimum Communications Inc
OPTU
$343M
| $3.41M | ﹤0.01% |
1,307,209
+295,995
| +29% | +$745K |
|
2433
Sanofi
SNY
$102B
| $3.4M | ﹤0.01% |
70,056
+27,824
| +66% | +$1.36M |
|
|
LUCK
2434
Lucky Strike Entertainment
LUCK
$929M
| $3.39M | ﹤0.01% |
247,747
-6,645
| -3% | -$85.7K |
|
|
BORR
2435
Borr Drilling
BORR
$1.24B
| $3.39M | ﹤0.01% |
494,679
-15,313
| -3% | -$100K |
|
|
NAPA
2436
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $3.37M | ﹤0.01% |
362,086
+25,328
| +8% | +$232K |
|
2437
Sumitomo Mitsui Financial
SMFG
$158B
| $3.35M | ﹤0.01% |
284,446
+96,206
| +51% | +$1.03M |
|
2438
Banco Santander
SAN
$207B
| $3.33M | ﹤0.01% |
688,771
+175,556
| +34% | +$733K |
|
|
BAND
2439
Bandwidth Inc
BAND
$1.49B
| $3.33M | ﹤0.01% |
182,354
-3,150
| -2% | -$49.6K |
|
|
CDMO
2440
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $3.33M | ﹤0.01% |
496,454
+10,125
| +2% | +$69.7K |
|
2441
Rush Street Interactive
RSI
$2.92B
| $3.3M | ﹤0.01% |
507,003
-7,933
| -2% | -$42.7K |
|
2442
AnaptysBio
ANAB
$1.63B
| $3.29M | ﹤0.01% |
146,271
+1,451
| +1% | +$34.4K |
|
2443
8x8 Inc
EGHT
$318M
| $3.29M | ﹤0.01% |
1,218,082
-21,269
| -2% | -$64.3K |
|
|
TSVT
2444
DELISTED
2seventy bio
TSVT
| $3.29M | ﹤0.01% |
614,525
-4,790
| -0.8% | -$22.5K |
|
|
NFBK
2445
DELISTED
Northfield Bancorp
NFBK
| $3.29M | ﹤0.01% |
338,028
+306
| +0.1% | +$3.35K |
|
|
SRDX
2446
DELISTED
Surmodics
SRDX
| $3.27M | ﹤0.01% |
111,592
+1,099
| +1% | +$35K |
|
2447
Phibro Animal Health
PAHC
$1.48B
| $3.27M | ﹤0.01% |
252,899
+8,241
| +3% | +$98.8K |
|
2448
Arrow Financial
AROW
$674M
| $3.26M | ﹤0.01% |
130,372
+1,454
| +1% | +$36.4K |
|
2449
Banco Bilbao Vizcaya Argentaria
BBVA
$155B
| $3.26M | ﹤0.01% |
275,037
+66,905
| +32% | +$669K |
|
|
SEMR
2450
DELISTED
Semrush
SEMR
| $3.25M | ﹤0.01% |
244,872
+4,785
| +2% | +$57.6K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.